A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers
Open Access
- 8 April 2004
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (7) , 1135-1142
- https://doi.org/10.1111/j.1538-7836.2004.00732.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Laboratory Diagnosis of Congenital von Willebrand DiseaseSeminars in Thrombosis and Hemostasis, 2002
- NAMD2: Greater Scalability for Parallel Molecular DynamicsJournal of Computational Physics, 1999
- Molecular study of von Willebrand diseaseBlood Coagulation & Fibrinolysis, 1992
- Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxy-terminal 151 amino acids.The Journal of cell biology, 1991
- von Willebrand Factor and Platelet FunctionaAnnals of the New York Academy of Sciences, 1991
- Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric sizeBritish Journal of Haematology, 1989
- Site-directed mutagenesis by overlap extension using the polymerase chain reactionGene, 1989
- Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene.Journal of Clinical Investigation, 1988
- Identification of disulfide-bridged substructures within human von Willebrand factorBiochemistry, 1987
- Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's diseaseBritish Journal of Haematology, 1982